Author

Lena Kubanek

Institutions: Universität Ulm, University Hospital Ulm

Observed institutions: Universität Ulm, University Hospital Ulm

OpenAlex ID: A5012586574

Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial

2020 · Silke Kapp-Schwoerer, Daniela Weber, et al. · Blood · 121

Assessment of the Genomic Landscape of Intermediate Risk Acute Myeloid Leukemia As Defined By 2010 ELN Risk Classification

2018 · Ekaterina Panina, Frank G. Rücker, et al. · Blood

Works count: 2

Citation count: 121

H-index: 1

I10-index: 1